URGN
Urogen Pharma
$42.24
−$2.76 (−6.13%)Sep 10, 2026
Key metrics
The numbers that frame URGN today
- Market cap
- $2.06B
- P/E (TTM)
- -21.1
- EV / FCF
- -13.7
- Gross margin
- 90.8%
- EV / Sales
- 11.6
- ROIC
- -34.7%
- Div yield
- 0%
- 52wk Low
- $15.86
- 52wk High
- $50.81
Growth
Revenue and earnings trend for URGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about URGN
Is Urogen Pharma a good buy?
Yes. Urogen Pharma has excellent momentum, and it outweighs the poor quality here. Growth looks excellent, which supports the long-term business case. We think Urogen Pharma is selling at a high price, which cuts against the buy case.
What is the market capitalization of URGN?
Urogen Pharma's market capitalization is $2.06B.
What is the P/E ratio for URGN stock?
Urogen Pharma's current P/E ratio is -21.1.
What is the 52-week high for URGN stock?
The 52-week high for Urogen Pharma is $50.81. The current close of $42.24 is 16.9% below that high.
What is the 52-week low for URGN stock?
The 52-week low for Urogen Pharma is $15.86. The current close of $42.24 is 166.3% above that low.
Does URGN stock pay dividends?
Urogen Pharma does not currently show a dividend per share in the company data.